echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Qilu Cefepime Hydrochloride for Injection passed the consistency evaluation

    Qilu Cefepime Hydrochloride for Injection passed the consistency evaluation

    • Last Update: 2021-05-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 20, the official website of the State Food and Drug Administration showed that Qilu Pharmaceutical's cefepime hydrochloride for injection passed the consistency evaluation and was the first in China.


    Source: official website of the State Food and Drug Administration

    Cefepime hydrochloride can inhibit bacterial cell wall synthesis.


    Cefepime hydrochloride currently on the market in China only has one dosage form for injection.


    Application status of consistency evaluation of cefepime hydrochloride for injection

    Source: Meinenet MED2.


    At present, 9 companies have submitted supplementary applications for the consistency evaluation of cefepime hydrochloride for injection.


    Qilu Pharmaceutical has reviewed injections

    Source: Meinenet MED2.


    Among the 18 over-reviewed injections, Cefepime Hydrochloride, Palonosetron Hydrochloride Injection, Ondansetron Hydrochloride Injection, Irinotecan Hydrochloride Injection, Fasudil Hydrochloride Injection, Oxaliplatin Seven injections for injection and bivalerudin for injection have been reviewed for the first time.


    A wealth of over-reviewed varieties allows Qilu Pharmaceutical to "make a big show" in the national centralized procurement.


    Qilu Pharmaceutical's products for consistency evaluation of injections (including new classifications for production)

    Note: With *, no company has reviewed

    Source: Meinenet MED2.


    According to data from Minai.


    Source: Minei.


    Note: The statistics are as of April 21.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.